Chaozhong Zou Ph.D.
Chaozhong has extensive experience in cell-related product development such as immortalized cell lines, stable reporter cell lines, and cell-based assays development. He is currently the CTO of Cell Therapy at Simnova Biotherapeutics. Prior to that he was the VP of Product Development, Cell Therapy at Wugen and Head, Vector Cell Bank and Analytics at Takeda. He was a Research Scientist at NorthShore University Health System, University of Chicago Medical School and conducted his Post Doctoral research at Northwestern University and Tufts University. At Targazyme, he oversees our cell therapy and FucoTIL program.